Overview

This conference brings together researchers from academic institutions and industry to discuss the utilization/deployment of biomarkers in research settings, the clinic, and point-of-care (POC) setting.

The focus of the conference begins with oncology (cancer) biomarkers but continues beyond into other disease areas such as cardiovascular disease biomarkers, CNS biomarkers, diabetes biomarkers, renal biomarkers, hepatic disease biomarkers.

Various classes of biomarkers are presented in this conference: Classical cancer biomarkers, molecular signatures for cancer based on gene expression profiles, microRNA-based biomarkers, protein expression-based biomarkers, and epigenetic biomarkers.

One of the revolutions currently taking place is the movement of diagnostics towards the point-of-care and more recently with a smartphone or other telemetry-based approach towards the mobile point-of-care (mPOC). This conference focuses on this emerging trend.

The ultimate goal of this conference is to bring together the stakeholders studying and utilizing biomarkers in many disease areas for up-to-date information exchange as well as extensive networking opportunities.

Keynote Speakers:
- Khusru Asadullah
Vice President/Head of Global Biomarkers, Bayer Healthcare Pharmaceuticals AG

- Mark Curran
VP Immunology Systems Pharmacology & Biomarkers, Janssen Pharmaceutical Research & Development/Johnson & Johnson

- Razelle Kurzrock
Director, Center for Personalized Cancer Therapy and Clinical Trials Office, Chief, Division of Hematology and Oncology, University of California-San Diego Moores Cancer Center

- Aydogan Ozcan
Chancellor's Professor, University of California Los Angeles

You can present your research on a poster while attending the meeting. Submit an abstract for consideration now! Poster Submission Deadline: 09 January 2015


Venue: San Diego Marriott Del Mar
Location: 11966 El Camino Real, San Diego, CA
Country: United States

Organiser Contact Details:
Jeff Fan
T: +1 510-857-4865
jeff@selectbio.us